Early treatment in multiple sclerosis may slow disease progression
New research findings suggest that early treatment of multiple sclerosis (MS), a chronic autoimmune disorder affecting the central nervous system, could significantly slow down the progression of the disease. Initiating medication and therapeutic treatments immediately after diagnosis was shown to delay the onset of debilitating symptoms and reduce long-term disability. In light of these important findings, healthcare professionals are now urging for earlier screenings and more prompt treatment plans to improve the quality of life for MS patients.
Source
βMultiple Sclerosis: Early Treatment Linked to Less Disability.β Medical News Today, MediLexicon International, www.medicalnewstoday.com/articles/multiple-sclerosis-early-treatment-less-disability. Accessed 31 Aug. 2023.